| Felicia Economide, FNP | |
|
2500 Metrohealth Dr, Cleveland, OH 44109-1900 | |
| (216) 778-7800 | |
| Not Available |
| Full Name | Felicia Economide |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 2500 Metrohealth Dr, Cleveland, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811689458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | CNP.0030205 (Ohio) | Primary |
| Entity Name | The Metrohealth System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053353896 PECOS PAC ID: 8628982949 Enrollment ID: O20031119000355 |
News Archive
Results from CREDO-Kyoto PCI/CABG Registry Cohort-2 show that percutaneous coronary intervention (PCI) was associated with significantly higher risk for serious adverse events in patients with triple vessel disease than coronary artery bypass grafting.
Frailty was associated with an increased risk of complications among patients who underwent outpatient hernia, breast, thyroid or parathyroid surgery, with the findings suggesting that surgeons should consider frailty rather than age when counseling and selecting patients for elective ambulatory surgery, according to a study published by JAMA Surgery.
According to a latest report released this Monday, Toronto has more HIV and AIDS cases than ever before, with an estimated one in 120 adults in the city now HIV-positive. In all of Ontario, the number of people living with HIV-AIDS grew by 31 per cent between 2003 and 2008 and that number continues to expand.
Titan Pharmaceuticals, Inc today announced that the National Institutes of Health (NIH) has awarded a Research and Research Infrastructure Grand Opportunities grant to the company through the American Reinvestment and Recovery Act of 2009 (ARRA). The two year grant for Probuphine clinical development is expected to provide approximately $7.6 million, with the first year award of approximately $ 5.6 million now made available to Titan by the NIH.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Felicia Economide, FNP 2500 Metrohealth Dr, Cleveland, OH 44109-1900 Ph: (440) 570-5010 | Felicia Economide, FNP 2500 Metrohealth Dr, Cleveland, OH 44109-1900 Ph: (216) 778-7800 |
News Archive
Results from CREDO-Kyoto PCI/CABG Registry Cohort-2 show that percutaneous coronary intervention (PCI) was associated with significantly higher risk for serious adverse events in patients with triple vessel disease than coronary artery bypass grafting.
Frailty was associated with an increased risk of complications among patients who underwent outpatient hernia, breast, thyroid or parathyroid surgery, with the findings suggesting that surgeons should consider frailty rather than age when counseling and selecting patients for elective ambulatory surgery, according to a study published by JAMA Surgery.
According to a latest report released this Monday, Toronto has more HIV and AIDS cases than ever before, with an estimated one in 120 adults in the city now HIV-positive. In all of Ontario, the number of people living with HIV-AIDS grew by 31 per cent between 2003 and 2008 and that number continues to expand.
Titan Pharmaceuticals, Inc today announced that the National Institutes of Health (NIH) has awarded a Research and Research Infrastructure Grand Opportunities grant to the company through the American Reinvestment and Recovery Act of 2009 (ARRA). The two year grant for Probuphine clinical development is expected to provide approximately $7.6 million, with the first year award of approximately $ 5.6 million now made available to Titan by the NIH.
› Verified 4 days ago
Amir Razavi, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Dr. Francois Fadell, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 18200 Lorain Ave, Moll Cancer Center At Fairview- Respiratory Institute, Cleveland, OH 44111 Phone: 216-444-6503 | |
Sana Hasan, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 Phone: 330-721-5700 | |
Catherine Frakes Vozzo, DO Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-4444 Fax: 216-445-6290 | |
Tarek Ashour, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave # Q7, Cleveland, OH 44195 Phone: 216-444-5040 | |
Mrs. Efewongbe Benedicta Oleghe, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2351 E 22nd Street, St Vincent's Charity Medical Center, Cleveland, OH 44115 Phone: 216-363-2725 | |
Dr. Toufik Z. Madhun, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave Dept Of, Cleveland, OH 44106 Phone: 216-844-1000 |